Wikisage, the free encyclopedia of the second generation, is digital heritage

Aspirin: Difference between revisions

From Wikisage
Jump to navigation Jump to search
mNo edit summary
Line 9: Line 9:
<ref>[http://www.e-mjm.org/2018/v73n6/refractory-kawasaki-disease.pdf A case report of refractory kawasaki disease]</ref>
<ref>[http://www.e-mjm.org/2018/v73n6/refractory-kawasaki-disease.pdf A case report of refractory kawasaki disease]</ref>


==Hutchinson Gliford Progeria==
==Hutchinson Gilford Progeria==
Low dosis Aspirin 2-3 mg/Kg body weight is recommended for prevention of cardiovascular and stroke complications
Low dosis Aspirin 2-3 mg/Kg body weight is recommended for prevention of cardiovascular and stroke complications
<ref>[https://www.ncbi.nlm.nih.gov/pubmed/20301300 Hutchinson-Gilford Progeria Syndrome]</ref>
<ref>[https://www.ncbi.nlm.nih.gov/pubmed/20301300 Hutchinson-Gilford Progeria Syndrome]</ref>

Revision as of 12:52, 24 January 2019

Aspirin is an NSAID [1] A recommendation of AAs-clopidogrel to maintain the patency of the stent following coronary intervention. Clopidogrel is a P2Y12 inhibiting platelet agent; the combination AAs Ticagrelor wasn´t better than clopidogrel+aspirin [2]

Kawasaki

Protocols recommend AAs and intravenous immunoglubin; however many cases have be shown to be refractory to this treatment [3]

Hutchinson Gilford Progeria

Low dosis Aspirin 2-3 mg/Kg body weight is recommended for prevention of cardiovascular and stroke complications [4]

ATC

Salicylic acid and derivates

  • Acetylsalicylic acid (INN)

N02BA01

Links

Level and variation on quality of care in China: a cross-sectional study for the acute myocardial infarction patients in tertiary hospitals in Beijing


Q18216 at Wikidata  Interwiki via Wikidata